Nanomedicine

Emerging Prospects
1. Auflage 2023
ISBN: 978-981-99-2138-6
Verlag: Springer

Buch, Englisch, 73 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 137 g

Reihe: SpringerBriefs in Applied Sciences and Technology

This book highlights the emerging paradigm of nanomedicine, intersecting two burgeoning fields of nanotechnology and medicine. Numerous publications have appeared in the literature over the years, especially in cancer nanomedicine. In a boarder sense, nanomedicine aims to apply the knowledge and tools of nanotechnology in a mission to diagnose early and prevent or treat diseases using biocompatible nanoparticles (NPs). Current research in nanomedicine and its prospects depend on creating new breakthroughs at the nexus of nanomaterials and biological systems, making use of non-toxic NPs and nano/biomaterials as smart theranostic systems for a variety of diseases including cancer, neurodegenerative, orthopedic, and cardiac diseases. This book provides a review on recent advancements of nanomedicine in the aforementioned emerging areas of nanomedicine.

Zielgruppe

Research

Autoren/Hrsg.

Tamil Selvan, Subramanian

Fachgebiete

• Naturwissenschaften Chemie Physikalische Chemie Molekulare Chemische Nanostrukturen
• Naturwissenschaften Physik Angewandte Physik Biophysik
• Naturwissenschaften Biowissenschaften Angewandte Biologie Biophysik
• Technische Wissenschaften Maschinenbau | Werkstoffkunde Technische Mechanik | Werkstoffkunde Materialwissenschaft: Biomaterialien, Nanomaterialien, Kohlenstoff
• Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie Verhaltenstherapie

Inhaltsverzeichnis

1.      Introduction to Nanomedicine

References

 

2.      Cancer Nanomedicine

2.1.              Emerging QDs and NPs as Bioimaging Probes

2.1.1.        NIR emitting QDs for Deep-Tissue Bimodal Imaging

2.1.2.        Au-NPs and Tripods for Bioimaging and Therapy

2.2.              NPs as Drug Carriers

2.2.1.        Iron Oxide NPs

2.2.2.        Silica-based carriers

2.2.3.        Graphene and Graphene Oxide as Carriers

2.2.4.        Peptide / Polymer Mediated Delivery

2.2.5.        Liposomes for Targeted delivery

2.3.              Photothermal Therapy

References

3.      Nanomedicine for Neurodegenerative Diseases

3.1.              Design of NPs for Inhibiting Protein Aggregation

3.1.1.        Au NPs

3.1.2.        Ceria NPs

3.2.              NP-based Drug Delivery Carriers

3.2.1.        Apolipoprotein

3.2.2.        Dendrimers, Peptides, and Inorganic NPs

References

 

4.      Nanomedicine for Orthopedics

References

5.      Nanomedicine for Cardiac Diseases

References

6.      Conclusions and Perspectives

References

Über Autor(innen)

Dr. Subramanian Tamil Selvan has over 25 years of research and teaching experience in nanomaterials and nanobiotechnology. Currently, he is a Chief Technology Officer and Chief Scientist at GSC & Alpha Biomedical Labs, Singapore. Earlier, he worked as a Principal Scientist (A*STAR Singapore), an Adjunct Associate Professor (NUS) and a Visiting Professor (KIST South Korea). His research covers a wide range of multifunctional nanoparticles and nanocomposites for diverse biomedical, energy and environment applications. He has authored over 100 publications and 1 book with a citation index of over 7000 and an h-index of 39. He is an inventor of 7 awarded patents (5 USA, 1 Europe, and 1 Korea) in nanomaterials.